Interpreting Breakthrough Infections Given Assortative Mixing of Partially Vaccinated Populations

在部分接种疫苗人群混合的情况下,如何解读突破性感染

阅读:1

Abstract

Declining vaccine coverage across the United States has increased the risk of outbreaks of vaccine-preventable diseases. Even when vaccines have low primary failure rates, conventional epidemic theory predicts a strongly nonlinear, positive relationship between vaccine coverage and the fraction of breakthrough infections in vaccinated individuals. These breakthrough infections may generate misconceptions that vaccines are not working and accelerate declines in confidence and coverage. Here, we set out to test predictions of conventional epidemic theory that assumes random mixing between individuals irrespective of vaccine status. In contrast to expectations from random mixing models, we find a far lower fraction of breakthrough infections in measles outbreak data from seven states in the United States. To explore this discrepancy, we evaluate an alternative, compartmental disease model that accounts for preferential mixing ('assortativity') between people with the same vaccination status. The model predicts significantly lower fractions of breakthrough infections, consistent with observations from measlesoutbreak data. Next, we leverage the deviation between statewide and school-level vaccine MMR coverage across kindergartens in sixteen states, finding substantial assortativity in all cases. Our model accounting for preferential mixing predicts the total number of breakthrough infections is nonlinear, peaking at intermediate coverage below vaccine-derived herd immunity. Nationally, 94% of counties that report MMR coverage are above the model-predicted breakthrough-maximizing coverage, suggesting that they are at risk for increasing breakthrough infections if coverage declines. Vaccination outreach and monitoring campaigns should develop proactive strategies to contextualize breakthrough infections before low levels of primary failure contributes to population-scale increases in preventable disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。